Free Trial

Bill Clinton sees this year's Clinton Global Initiative as a 'counterweight' to aid cuts

Former U.S. President Bill Clinton speaks during the Clinton Global Initiative, on Wednesday, Sept. 24, 2025, in New York. (AP Photo/Andres Kudacki)

Key Points

  • Former President Bill Clinton opened the annual Clinton Global Initiative, expressing concerns about rising political violence and the dismantling of aid programs.
  • The conference announced a partnership to provide an HIV prevention drug for $40 per person yearly in low- and middle-income countries, partially as a response to foreign aid cuts.
  • Activist and philanthropist Abigail Disney emphasized the need for philanthropies to be more proactive in their giving to address societal issues.
  • Clinton reiterated the initiative's goal to create solutions and foster hope in communities despite the challenges faced in recent months.
  • MarketBeat previews top five stocks to own in October.

NEW YORK (AP) — Former President Bill Clinton opened the annual meeting of the Clinton Global Initiative Wednesday with a list of things that worry him.

“It would be irresponsible, almost jarring, for us to take off and not acknowledge the traumatic rise in political violence that we’ve seen in our country,” Clinton said about the shooting deaths of conservative activist Charlie Kirk and former Minnesota House Speaker Melissa Hortman and her husband, Mark. “We’re pulling further and further away from one another.”

Clinton said he worried about the dismantling of domestic and foreign assistance programs, “the war on science and public health,” cuts to education, trade wars, and being “at risk of losing our freedom of speech.”

“We’re trying to do everything we can to provide a counterweight to a lot of the negative things that have taken place in the last several months,” Clinton said of the two-day conference, which shifted its format to create working groups to tackle many of the issues he outlined.

The conference’s biggest announcement on Wednesday was a partnership between the Clinton Health Access Initiative, Dr. Reddy’s Laboratories, Unitaid, and Wits RHI that will provide Gilead Sciences’ HIV prevention drug lenacapavir in 120 low- and middle-income countries for $40 a person each year, starting in 2027. The Gates Foundation announced a similar agreement with the Indian manufacturer Hetero Labs.

Clinton said the move was partially in response to foreign aid cuts from President Donald Trump’s administration, which he said could lead to more than 6 million more HIV cases and potentially 4 million more deaths in Africa. In July, GOP leaders stopped an additional cut of $400 million to PEPFAR, a program combating HIV/AIDS credited with saving millions of lives since its creation under then-President George W. Bush.

Points of Light Chairman Neil Bush said PEPFAR and the way it has helped so many in Africa has always been a point of family pride. And though he hasn’t talked to his brother, former President George W. Bush, about the new program announced at the Clinton Global Initiative, Neil Bush said he sees it as a way philanthropy can help fill in gaps.

“It seems like America’s withdrawal from the world is having terrible ramifications, in my personal view,” he said, adding that Points of Light hopes to increase the help it provides through its ambitious plan to double the number of volunteers in America in the next 10 years.

Activist and philanthropist Abigail Disney urged Clinton Global Initiative attendees to be more aggressive in their giving and encouraged them to support cultural movements instead of programs.

“I don’t care where you are on the political spectrum -- there is mistrust, there’s fear and there is anger, and we should all be very alarmed,” Disney said. “And I hang around big philanthropies these days and I don’t see any alarm. I don’t think that’s because they’re not alarmed. I think that’s because they’re afraid. Everybody’s afraid.”

However, President Clinton said that the Clinton Global Initiative, which launched in 2005, has always looked to create solutions.

“If we hold our heads high, keep our eyes and ears open and deal with others with an outstretched hand and not a clenched fist, we’ve got a chance to keep hope alive,” he said. “We have the chance to make a meaningful difference in other people’s lives.”

_____

Associated Press coverage of philanthropy and nonprofits receives support through the AP’s collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content. For all of AP’s philanthropy coverage, visit https://apnews.com/hub/philanthropy.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI vs. Wall Street: 5 Names It Loves Right Now
3 Growth Stocks to Buy Now… and 3 to Dump Fast
These Sectors Are On Fire: Breaking Down the Market’s Biggest Gainers

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines